TY - CHAP A1 - Tjaša Vižintin-Cuderman A2 - Mojca Božič-Mijovski A3 - Aleksandra Antović A4 - Polona Peternel A5 - Matija Kozak A6 - Mojca Stegnar ED1 - Andrea Luigi Tranquilli Y1 - 2011-11-09 PY - 2011 T1 - Association of Haemostasis Activation Markers with Thrombophilia and Venous Thromboembolism N2 - Thrombophilia(s) is a condition of increased tendency to form blood clots. This condition may be inherited or acquired, and this is why the term is often used in plural. People who have thrombophilia are at greater risk of having thromboembolic complications, such as deep venous thrombosis, pulmonary embolism or cardiovascular complications, like stroke or myocardial infarction, nevertheless those complications are rare and it is possible that those individuals will never encounter clotting problems in their whole life. The enhanced blood coagulability is exacerbated under conditions of prolonged immobility, surgical interventions and most of all during pregnancy and puerperium, and the use of estrogen contraception. This is the reason why many obstetricians-gynecologysts became involved in this field aside the hematologists: women are more frequently at risk. The availability of new lab tests for hereditary thrombophilia(s) has opened a new era with reflections on epidemiology, primary healthcare, prevention and prophylaxis, so that thrombophilia is one of the hottest topics in contemporary medicine. BT - Thrombophilia SP - Ch. 2 UR - https://doi.org/10.5772/26357 DO - 10.5772/26357 SN - PB - IntechOpen CY - Rijeka Y2 - 2019-11-20 ER -